These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6037061)

  • 21. Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.
    Shapiro WR; Ausman JI; Rall DP
    Cancer Res; 1970 Sep; 30(9):2401-13. PubMed ID: 5475484
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis of N-(2-chloroethyl)amides of amino acids as potential cytotoxic agents.
    Chakrabarti JK; Friedman OM
    J Med Chem; 1967 Mar; 10(2):285-7. PubMed ID: 6034086
    [No Abstract]   [Full Text] [Related]  

  • 23. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
    Wilson CB; Boldrey EB; Enot KJ
    Cancer Chemother Rep; 1970 Aug; 54(4):273-81. PubMed ID: 4334089
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
    Shapiro WR
    J Natl Cancer Inst; 1971 Feb; 46(2):359-68. PubMed ID: 4256014
    [No Abstract]   [Full Text] [Related]  

  • 25. Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by vitamin A and caffeine.
    Cohen MH
    J Natl Cancer Inst; 1972 Apr; 48(4):927-32. PubMed ID: 5023690
    [No Abstract]   [Full Text] [Related]  

  • 26. Potential antimalarial compounds. IX. Pyrimidine derivatives of urea and guanidine.
    Urbański T; Serafin B; Zylowski J
    J Med Chem; 1967 Jul; 10(4):521-5. PubMed ID: 6037035
    [No Abstract]   [Full Text] [Related]  

  • 27. The uptake, distribution, and antitumor activity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the murine glioma.
    Levin VA; Shapiro WR; Clancy TP; Oliverio VT
    Cancer Res; 1970 Oct; 30(10):2451-5. PubMed ID: 5474173
    [No Abstract]   [Full Text] [Related]  

  • 28. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
    [No Abstract]   [Full Text] [Related]  

  • 29. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
    Walker MD; Hurwitz BS
    Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
    [No Abstract]   [Full Text] [Related]  

  • 30. Potential carcinostatic agents. I. Derivatives and analogs of 1-(2-hydroxyethyl)-3-(4-tolyl)urea.
    Nelson HG; Shelton FJ; Wetzel WH
    J Med Chem; 1967 Jul; 10(4):735-6. PubMed ID: 6037073
    [No Abstract]   [Full Text] [Related]  

  • 31. Pteridinecarboxamide diuretics. I. Reaction of 4,6-diamino-5-nitrosopyrimidines with substituted malonamides.
    Osdene TS; Santilli AA; McCardle LE; Rosenthale ME
    J Med Chem; 1966 Sep; 9(5):697-701. PubMed ID: 5969042
    [No Abstract]   [Full Text] [Related]  

  • 32. Alkylating activity of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds.
    Wheeler GP; Chumley S
    J Med Chem; 1967 Mar; 10(2):259-61. PubMed ID: 6034073
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis of possible cancer chemotherapeutic agents based on enzyme rationale. VI. Allylamine derivatives.
    Tsou KC; Damle SB; Crichlow RW; Ravdin RG; Blunt HW
    J Pharm Sci; 1967 Apr; 56(4):484-8. PubMed ID: 6034545
    [No Abstract]   [Full Text] [Related]  

  • 34. A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Jun; 32(6):1278-9. PubMed ID: 4113144
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.
    Bray DA; DeVita VT; Adamson RH; Oliverio VT
    Cancer Chemother Rep; 1971 Jun; 55(3):215-20. PubMed ID: 5115843
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism of action of (2-haloethyl)nitrosoureas on DNA. Isolation and reactions of postulated 2-(alkylimino)-3-nitrosooxazolidine intermediates in the decomposition of 1,3-bis(2-chloroethyl)-, 1-(2-chloroethyl)-3-cyclohexyl-, and 1-(2-chloroethyl)-3-(4'-trans-methylcyclohexyl)-1-nitrosourea.
    Lown JW; Chauhan SM
    J Med Chem; 1981 Mar; 24(3):270-9. PubMed ID: 7265113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of nitro groups in the antiedemic action of butyric acid derivatives and their esters].
    Ladinskaia MIu
    Biull Eksp Biol Med; 1968 Jan; 65(1):69-72. PubMed ID: 5652292
    [No Abstract]   [Full Text] [Related]  

  • 38. Self-consistent-field comparative studies of some nitrosoureas and nitrosamides.
    Sapse AM; Snyder G; Osorio L
    Cancer Res; 1984 May; 44(5):1904-7. PubMed ID: 6713391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examination of newly synthesized 2-chloroethylnitrosoureas in preterminal leukemia L 5222 and in two transplanted neurogenic tumors.
    Berger M; Zeller WJ; Eisenbrand G; Lin PZ; Nakra M; Schmähl D
    Arzneimittelforschung; 1982; 32(5):481-4. PubMed ID: 6285938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New reactions with nitrosouracil derivatives. V. Alkylation of 5-nitrosouracils].
    Goldner H; Dietz G; Carstens E
    Justus Liebigs Ann Chem; 1966 Oct; 698():145-8. PubMed ID: 5977095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.